Leelasiri A. Periorbital Dermatitis from EGFR Tyrosine Kinase Inhibitor. GMSMJ [Internet]. 2024 Jan. 8 [cited 2024 May 13];4(1):43-5. Available from: https://he02.tci-thaijo.org/index.php/gmsmj/article/view/267213